{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01589549",
      "OrgStudyIdInfo": {
        "OrgStudyId": "2011/128"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "CTN 2012/0174",
            "SecondaryIdType": "Other Identifier",
            "SecondaryIdDomain": "Therapeutics Goods Administration, Government of Australia"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "Royal Perth Hospital",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Mesenchymal Stromal Cells for Acute Graft Versus Host Disease",
      "OfficialTitle": "A Phase 2 Trial of Standard of Care Treatment Versus Mesenchymal Stromal Cell Therapy Together With Standard of Care for the Treatment of de Novo Acute Graft Versus Host Disease Following Allogeneic Bone Marrow Transplantation"
    },
    "StatusModule": {
      "StatusVerifiedDate": "June 2015",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "April 2012"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 2015",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2016",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "April 26, 2012",
      "StudyFirstSubmitQCDate": "April 30, 2012",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "May 2, 2012",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "June 8, 2015",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "June 9, 2015",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor-Investigator",
        "ResponsiblePartyInvestigatorFullName": "R.P.Herrmann",
        "ResponsiblePartyInvestigatorTitle": "Director, Cell and Tissue Therapies, Royal Perth Hospital",
        "ResponsiblePartyInvestigatorAffiliation": "Royal Perth Hospital"
      },
      "LeadSponsor": {
        "LeadSponsorName": "R.P.Herrmann",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Royal Perth Hospital",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "A randomised study of corticosteroid therapy with or without mesenchymal stromal cell therapy for newly diagnosed acute graft versus host disease after bone marrow transplantation or donor lymphocyte therapy.\n\nIt is hypothesised that mesenchymal stromal cell therapy will be superior",
      "DetailedDescription": "Patients with newly diagnosed untreated acute graft versus host disease grades 2-4 will receive methylprednisolone 2.5mg/kg intravenously and randomised to receive or not receive allogeneic human mesenchymal stromal cells 2X10E6 intravenously on two occasions at weekly intervals"
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Acute GVH Disease"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Acute graft versus host disease",
          "Bone marrow transplantation",
          "Mesenchymal stromal cells"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "66",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Mesenchymal stromal cell therapy",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Mesenchymal stromal cell therapy in addition to corticosteroid therapy",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Mesenchymal stromal cell therapy"
              ]
            }
          },
          {
            "ArmGroupLabel": "Corticosteroid therapy",
            "ArmGroupType": "Active Comparator",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Mesenchymal stromal cell therapy"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Mesenchymal stromal cell therapy",
            "InterventionDescription": "One arm will be randomised to receive mesenchymal stromal cell therapy in addition to corticosteroid therapy",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Corticosteroid therapy",
                "Mesenchymal stromal cell therapy"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Methylprednisolone",
                "Mesenchymal stem cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Survival at one year after onset of graft versus host disease",
            "PrimaryOutcomeTimeFrame": "One year"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Response at 14 days after commencement of treatment for acute graft versus host disease",
            "SecondaryOutcomeTimeFrame": "14 days"
          },
          {
            "SecondaryOutcomeMeasure": "Response at 28 days after commencement of treatment of acute graft versus host disease",
            "SecondaryOutcomeTimeFrame": "28 days"
          },
          {
            "SecondaryOutcomeMeasure": "Incidence of severe infection",
            "SecondaryOutcomeTimeFrame": "One year"
          },
          {
            "SecondaryOutcomeMeasure": "Disease free survival at one year",
            "SecondaryOutcomeTimeFrame": "One year"
          },
          {
            "SecondaryOutcomeMeasure": "Time to treatment failure, requiring salvage therapy",
            "SecondaryOutcomeTimeFrame": "28 days"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nGrades 2-4 acute graft versus host disease after bone marrow transplantation up to day +180 after transplantation\n\nAge 18-55 years\n\nMust be receiving a calcineurin inhibitor\n\nExclusion Criteria:\n\nFailure to sign informed consent\nCorticosteroid therapy for 72 hours or greater\nECOG score equal to or greater than 3",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "55 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Duncan Purtill, MB, BS",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+61 8 61523788",
            "CentralContactEMail": "duncan.purtill@health.gov.au"
          },
          {
            "CentralContactName": "Richard Herrmann, MB, BS",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+61 8 92241987",
            "CentralContactEMail": "richard.herrmann@health.wa.gov.au"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Duncan Purtill, MB, BS",
            "OverallOfficialAffiliation": "Royal Perth Hospital",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Royal Perth Hospital",
            "LocationStatus": "Recruiting",
            "LocationCity": "Perth",
            "LocationState": "Western Australia",
            "LocationZip": "6000",
            "LocationCountry": "Australia",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Megan Margaria, BN",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+61 8 92247038",
                  "LocationContactEMail": "megan.margaria@health.wa.gov.au"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000006086",
            "ConditionMeshTerm": "Graft vs Host Disease"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000007154",
            "ConditionAncestorTerm": "Immune System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M8341",
            "ConditionBrowseLeafName": "Graft vs Host Disease",
            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9352",
            "ConditionBrowseLeafName": "Immune System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T2832",
            "ConditionBrowseLeafName": "Homologous Wasting Disease",
            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T170",
            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
            "ConditionBrowseLeafAsFound": "Acute Graft Versus Host Disease",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC20",
            "ConditionBrowseBranchName": "Immune System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "D000008775",
            "InterventionMeshTerm": "Methylprednisolone"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000000893",
            "InterventionAncestorTerm": "Anti-Inflammatory Agents"
          },
          {
            "InterventionAncestorId": "D000000932",
            "InterventionAncestorTerm": "Antiemetics"
          },
          {
            "InterventionAncestorId": "D000001337",
            "InterventionAncestorTerm": "Autonomic Agents"
          },
          {
            "InterventionAncestorId": "D000018373",
            "InterventionAncestorTerm": "Peripheral Nervous System Agents"
          },
          {
            "InterventionAncestorId": "D000045505",
            "InterventionAncestorTerm": "Physiological Effects of Drugs"
          },
          {
            "InterventionAncestorId": "D000005765",
            "InterventionAncestorTerm": "Gastrointestinal Agents"
          },
          {
            "InterventionAncestorId": "D000005938",
            "InterventionAncestorTerm": "Glucocorticoids"
          },
          {
            "InterventionAncestorId": "D000006728",
            "InterventionAncestorTerm": "Hormones"
          },
          {
            "InterventionAncestorId": "D000006730",
            "InterventionAncestorTerm": "Hormones, Hormone Substitutes, and Hormone Antagonists"
          },
          {
            "InterventionAncestorId": "D000018696",
            "InterventionAncestorTerm": "Neuroprotective Agents"
          },
          {
            "InterventionAncestorId": "D000020011",
            "InterventionAncestorTerm": "Protective Agents"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M13272",
            "InterventionBrowseLeafName": "Prednisolone",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M1833",
            "InterventionBrowseLeafName": "Methylprednisolone Acetate",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M10901",
            "InterventionBrowseLeafName": "Methylprednisolone",
            "InterventionBrowseLeafAsFound": "Induced",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M10902",
            "InterventionBrowseLeafName": "Methylprednisolone Hemisuccinate",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M229437",
            "InterventionBrowseLeafName": "Prednisolone acetate",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M211896",
            "InterventionBrowseLeafName": "Prednisolone hemisuccinate",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M248768",
            "InterventionBrowseLeafName": "Prednisolone phosphate",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3369",
            "InterventionBrowseLeafName": "Anti-Inflammatory Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M3403",
            "InterventionBrowseLeafName": "Antiemetics",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M8033",
            "InterventionBrowseLeafName": "Gastrointestinal Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M8199",
            "InterventionBrowseLeafName": "Glucocorticoids",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M8941",
            "InterventionBrowseLeafName": "Hormones",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M8940",
            "InterventionBrowseLeafName": "Hormone Antagonists",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M19926",
            "InterventionBrowseLeafName": "Neuroprotective Agents",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M21022",
            "InterventionBrowseLeafName": "Protective Agents",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "Infl",
            "InterventionBrowseBranchName": "Anti-Inflammatory Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "ANeo",
            "InterventionBrowseBranchName": "Antineoplastic Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          },
          {
            "InterventionBrowseBranchAbbrev": "AnEm",
            "InterventionBrowseBranchName": "Antiemetics"
          },
          {
            "InterventionBrowseBranchAbbrev": "NeuroAg",
            "InterventionBrowseBranchName": "Neuroprotective Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "Gast",
            "InterventionBrowseBranchName": "Gastrointestinal Agents"
          }
        ]
      }
    }
  }
}